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ompliance with an increasing number of federal and, to a lesser extent, state 
laws and regulations is a significant issue for all major research institutions. It 
consumes resources today at an increasing rate and burdens investigators with 
administrative requirements that compete with their academic pursuits. Areas where 
compliance issues are currently significant include human subjects research, research 
involving animals, conflict-of-interest, research integrity, and related research areas 
such as biological safety and export controls. All of these compliance areas serve as 
resource-allocation challenges for research administrators seeking to maximize the total 
campus impact of increasingly-scarce funding. Further, they exist to foster the public 
policy of conducting research in a safe and ethical manner. 
 
Human subjects research, review by 
Institutional Review Boards (IRBs), and 
potential federal sanctions have been 
front-page news for the past five or six 
years. Most institutions seeking federal 
funding have augmented their human 
research protection programs, often at the 
expense of other priorities. At the 
University of Missouri-Columbia (MU), 
we have gone from two part-time IRB 
administrators to ten full-time personnel 
supporting our two boards. Still, we need 
additional staff if we are to respond 
successfully to the major issue considered 
critical by our investigator population: 
time-to-approval of protocols. To 
complicate matters, we are currently 
engaged in IRB accreditation through the 
Association for Accreditation of Human 
Research Protection Programs 
(AAHRPP). Our involvement in the 
accreditation process at this point is a by-
product of our affiliation with a 
collocated Veterans Administration 
hospital, but we hope that the expense 
and time expended in accreditation will 
eventually be worth the investment. On 
the health-sciences side of the house, we 
desperately need additional attention to 
billing compliance and audits of clinical 
trials—both areas fraught with the 
opportunity for regulatory disaster. One 
point of continuing investigator anxiety is 
that of training. We continually refine our 
on-line web sites and training modules to 
reflect the reality that scientists and 
faculty in general don’t like to be 
“tested.” 
Animal use in research presents 
another fiscal challenge that daily 
confronts MU’s research administration. 
A recent review by an external panel 
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demonstrated that MU has (in 2003 
dollars) about $97 million in research-
animal infrastructure needs. Coupled 
with an estimated $70 million in plant-
growth-facility needs, this represents a 
major fiscal hurdle for the campus. In 
addition, we have had to deal with 
startup costs for our Life Sciences Center 
vivarium as well as funding service-and-
maintenance contracts for the equipment 
therein. Similar to human protection 
program accreditation, the Association 
for Assessment and Accreditation of 
Laboratory Animal Care, International 
(AAALAC) provides accreditation for 
MU’s animal research facilities, except for 
those in the College of Agriculture, Food 
and Natural Resources (CAFNR). 
Bringing CAFNR under the AAALAC 
umbrella has generated much 
consternation regarding potential costs 
and benefits. In addition, per diem 
charges and electronic veterinary medical 
records are two areas where much effort 
recently has been expended, as it has 
been on the issue of investigator training 
in both basic animal-care as well as 
specialty areas. Presently, MU invests 
considerable staff time and effort in self-
disclosing animal-care compliance issues 
to DHHS’s Office of Laboratory Animal 
Welfare. Of perhaps greater concern is 
administration of our Occupational 
Health-and-Safety Program for research 
animal workers. Mandated by our 
Collected Rules and Regulations (CRRs), 
enrollment in the program is required for 
MU employees and students, but the 
university’s role is less clear in regard to 
non-MU employees (such as federal 
scientists and technicians) conducting 
research on campus under a variety of 
memoranda-of-understanding. 
Conflicts-of-interest have raised 
compliance antennae nationwide over the 
past several years, especially as an 
offshoot of well-publicized controversy at 
the National Institutes of Health. MU 
currently has two conflict-of-interest 
policies in its CRRs: one is a “general” 
statement most directly applicable to 
individual financial conflicts in the 
typical business context, and the other 
resulted from the mid-‘90s mandate that 
PHS or NSF grantee institutions maintain 
an appropriate written and enforced 
policy on conflict of interest consistent 
with provisions in 42 CFR Part 50 and 45 
CFR Part 94 and the NSF Grant Policy 
Manual. The existence of these two 
policies has produced an interesting 
result, in that the aforementioned 
“general” policy proscribes MU 
employees using their university status in 
engineering contracts with outside 
business entities in which such 
employees have a “direct or indirect 
financial interest.” This “direct or 
indirect” threshold has been interpreted 
to apply also in the context of research 
grants. It is the federal de minimus 
standards which appear in the second 
policy and on MU’s grant-data form, and 
thus investigators who may in fact have a 
“direct or indirect” financial interest that 
does not exceed $10,000 per annum or 
five percent equity may fail to disclose 
and thus be out of compliance with the 
general policy. Readers whose campuses 
are members of multi-campus university 
systems will appreciate the cumbersome 
nature of getting such policies revised. In 
addition, neither policy addresses the 
issue of institutional conflict-of-interest, 
which failing will become apparent as 
MU’s IRBs move forward toward 
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AAHRPP accreditation. Our campus 
Conflict-of-Interest Committee coor-
dinates well with our IRBs because the 
IRB compliance officers sit as ex officio 
members on the former committee. A 
challenge remaining for this committee is 
effective annual review and audit of 
those management plans it has required. 
Research integrity remains bright on 
the radar screens of university research 
compliance officers. As expected, the 
federal Office of Research Integrity 
within DHHS has recently promulgated 
both amended definitions of scientific 
misconduct and a revised policy for 
responding to allegations of research 
dishonesty. The University of Missouri 
policy has in turn been revised and the 
draft submitted for review, comment and 
action by System officials. Further 
concerns focus on the currently-
suspended Responsible Conduct of 
Research (RCR) initiative from DHHS 
and how much faculty time eventually 
will be absorbed both presenting and 
taking the required courses of instruction. 
A recent report1 suggests that the amount 
of research misconduct actually occurring 
at U.S. universities may be 
underestimated, supporting the ongoing 
educational efforts focused on RCR. 
Related compliance areas currently 
taking considerable MU time and 
resources include biological safety and 
the Institutional Biosafety Committee 
(IBC). Recent federal guidance indicates 
that all recombinant-DNA research 
proposals should be reviewed at a 
convened IBC meeting, and further that 
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2005.  Scientists behaving badly. Nature 435: 737-
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such meetings should be open to the 
public when practicable. Similar 
compliance committee meetings have not 
traditionally been open to the public, nor 
have their minutes been accessible via 
state open-records law. The USA Patriot 
Act appears to have sufficient 
congressional support to continue 
generally un-amended; thus, rules 
applying to Select Agents will remain a 
part of research compliance into the 
foreseeable future. 
At MU, we are fortunate to be home 
to the nation’s most powerful research 
reactor, with the attendant radiation 
safety and Nuclear Regulatory 
Commission issues. Our Radiation Safety 
Committee constantly engages in 
oversight of radioactive isotopes on 
campus. Hazardous materials manage-
ment is a collateral area that requires 
constant attention, and MU’s Office of 
Research partners with the campus office 
of Environmental Health & Safety in 
managing biosafety, radiation safety, and 
hazardous materials handling. 
Export controls loom as the single 
regulatory issue in university research 
compliance with the potential for 
significant resource allocation in the 
immediate future. Although current 
export control regulations have been in 
place for many years, universities have 
traditionally relied on what is known as 
the “fundamental research exclusion” to 
exempt the majority of research projects 
from Department of Commerce licensing 
requirements. In fact, a quick review of 
existing export control regulations 
reveals that these are complicated rules 
administered by three major federal 
departments: Commerce, State and 
Treasury. Whereas patently military 
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technology, governed by Department of 
State through International Traffic in 
Arms Regulations (ITAR), is generally 
easily recognized, the so-called “deemed 
export” rules of the Export 
Administration Regulations (EAR) 
administered by the Department of 
Commerce are in practice much more 
difficult to apply. “Dual use” technology 
appearing on the Commerce Control List 
(CCL) implicates an appropriate license 
when such technology is even discussed 
with a non-U.S. citizen or non-
permanent-resident from any of the 
countries listed on the Commerce 
Country Chart, unless such interaction 
occurs as part of fundamental research 
that is currently excluded under National 
Security Decision Directive 189. To date, 
universities have focused on those 
actions that will preserve their excluded 
status, such as refusing to accept 
restrictions on publications, refusing to 
accept restrictions on access by foreign 
nationals, and so forth. However, 
Commerce recently completed the notice-
and-comment portion of a proposed 
rulemaking that would change the 
definition of equipment “use” and 
require as well that the country of birth 
be used to evaluate the license 
requirement on the Commerce Country 
Chart, rather than the country from 
which an individual emigrated to the 
United States. Compliance with existing 
export control requirements will require 
reallocation of existing administrative 
staff by almost all research institutions; 
compliance with the proposed changes, 
should they be implemented, will require 
a significant investment in additional 
staff. Similar changes to contractual 
language have recently been proposed by 
the Department of Defense. Not yet 
discussed in most national educational 
media is the provision of “services” to 
foreign nationals from those countries 
listed by the Office of Foreign Assets 
Control in the Department of Treasury. 
Coming hard on the heels of recent 
compliance challenges in human subjects 
oversight, research animal welfare, and 
biologicals under the Patriot and 
Bioterrorism acts, the potential for 
additional staff in any administrative 
compliance function will be hard to 
justify to hard-pressed senior 
administrators. At MU, our system-wide 
leadership has called for a reduction in 
administrative positions, and so it is 
unlikely that we will be able to add 
significant staff absent some sort of 
emergent situation. However, that 
prospect does raise an important public 
policy question: “Where will the 
institution get the wherewithal to meet 
these significant new compliance 
challenges?” At MU, the recurring rate 
budget needs of compliance compete 
directly with needs for recurring faculty 
rate, although many of the most 
significant compliance issues relate 
primarily to the institution’s research 
function. It is further a fact of life at our 
institution that we have long since 
exceeded the 26% administrative cap on 
facilities and administrative (F&A) costs: 
MU’s actual costs in this category 
currently exceed 32%. One option might 
be to suggest again that the federal 
government acquiesce to increasing the 
administrative cap. Using current MU 
fiscal data, an increase of 1.5% (to 27.5% 
of the negotiated rate) would result in 
recovering an additional $500,000 per 
annum, based on MU’s actual recovery of 
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F&A (which currently hovers at about 
18%). As an aside, increasing total 
recovery of F&A has been extremely 
problematic for our institution, given our 
land-grant status and the fact that we 
conduct significant state-supported 
research where rates of “indirect” are 
much lower than the federal level. 
Another option would be to campaign for 
line-item compliance amounts in the 
budgets of sponsored activities. One 
problem is that this puts the fiscal burden 
for compliance largely on activities that 
enjoy extramural sponsorship. Finally, 
requests for federal “handouts” have 
often been discussed at meetings where 
compliance budget challenges are 
discussed. 
A frequently-unappreciated portion 
of compliance costs consists of faculty 
and staff time. In fact, a recent study of 
IRB-related expenses2 factored in what all 
administrators know is the most 
expensive aspect of faculty-populated 
committees: the professional time of 
those committee members who could be 
pursuing scholarship or interacting with 
students instead. Indeed, the issue of how 
much committee service is “too much” 
led most institutions to vest their IRBs 
with Health Insurance Portability and 
Accountability Act (HIPAA) compliance 
functions rather than to form a “privacy 
committee,” which would have 
constituted one more entity requiring the 
input of faculty time. At MU, we are 
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currently developing comprehensive 
business plans for human subjects 
protections, animal care-and-use, and 
other compliance activities so that we can 
provide an accurate assessment of actual 
costs involved. Because we are dealing 
with a capped situation, even seemingly 
innocuous suggestions can have adverse 
fiscal consequences. As an example, a 
UM System committee recently required 
that all IRB records related to “medically 
invasive research” be archived for a 
period of ten years after research subjects 
reach age 21. Thus, for research involving 
newborns, the archival period could be 
up to 31 years. The fact is that there are 
no funds in our IRBs’ budgets to support 
this storage of records, even in electronic 
format, for this lengthy period of time. 
Fielding an effective compliance 
effort is obviously one of the major costs 
associated with running an ambitious 
institutional research program. The 
reality that most compliance upgrades 
have come only after catastrophic 
problems should not deter research 
officers from working aggressively to 
ensure that appropriate resources are 
allocated to compliance oversight in all 
areas. Public policy demands no less.
